hiv
Starpharma To Launch Anti-Viral Condoms
The first of its kind, the VivaGel® condom incorporates an antiviral compound to reduce the risk of exposure to viruses such as HIV, HSV and HPV.
7 Must-Read Stories In July 2014
A round-up of our top stories in July 2014; spanning ancient fossils to cosmic rays and the most high profile retraction in recent years.
MSF Treats First CMV Patients With Oral Drugs
Through a deal brokered with drug manufacturer Roche, CMV patients in Myanmar now need not endure painful injections directly into the eye.
CEL-SCI’s Phase III Trial Enrols Patients From Sri Lanka
CEL-SCI has begun enrolling patients from Sri Lanka for a Phase III trial for Multikine, an investigational treatment for head and neck cancer.
Amyloid Fibrils: The Link Between HIV & Alzheimer’s
Scientists have found that the protein fibrils which enhance the infective ability of HIV are toxic to neuronal cells even when disaggregated.
More Work On HIV In Laos Needed
Though the incidence of HIV/AIDS in Laos is relatively low, more could be done to improve awareness and treatment coverage, say health officials.
Cipla Gets FDA Approval For Generic HIV Drug
Tentative approval for a generic HIV drug for use outside of the United States has been granted to Indian manufacturer Cipla.
Recycled Plastic Finds New Role In Killing Drug-Resistant Fungi
Researchers have discovered a new, potentially life-saving application for polyethylene terephthalate, which is widely used to make plastic bottles.
How Golden Staph Breaks Down Our Immune Defenses
A new study shows how golden staph identifies key immune cells and 'nukes' our body's immune response when it enters our skin.
